Allegiant Private Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Allegiant Private Advisors's BMY Position: Q2 2021 in Review
Allegiant Private Advisors increased its Bristol-Myers Squibb (BMY) stake by 27% in Q2 2021, buying an estimated $105K and bringing the position to 7,632 shares worth $510K. The position accounts for 0.08% of the portfolio, ranked #105.
Allegiant Private Advisors first reported a position in BMY in Q4 2020 and has held it in 3 quarters since. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Allegiant Private Advisors held 7,632 shares of Bristol-Myers Squibb worth $510K as of Q2 2021.
- Allegiant Private Advisors bought 1,611 Bristol-Myers Squibb shares in Q2 2021, an estimated $105K.
- Bristol-Myers Squibb made up 0.08% of Allegiant Private Advisors's portfolio in Q2 2021, its #105 holding.
- Allegiant Private Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 3 quarters since.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.